<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>Historique des modifications</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Tms Rmn";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:0 0 5 0 0 0 0 2 0 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{margin-top:12.0pt;
	margin-right:-9.0pt;
	margin-bottom:3.0pt;
	margin-left:21.6pt;
	text-align:justify;
	text-indent:-21.6pt;
	page-break-after:avoid;
	background:#BBCBDD;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h2
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:28.8pt;
	text-indent:-28.8pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h3
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:36.0pt;
	text-indent:-36.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;
	font-style:italic;}
h4
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:43.2pt;
	text-indent:-43.2pt;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h5
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:50.4pt;
	text-indent:-50.4pt;
	font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;
	font-style:italic;}
h6
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:57.6pt;
	text-indent:-57.6pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:64.8pt;
	text-indent:-64.8pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:72.0pt;
	text-indent:-72.0pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:79.2pt;
	text-indent:-79.2pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0cm;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
p.SOPnTextinTables, li.SOPnTextinTables, div.SOPnTextinTables
	{mso-style-name:"SOPn Text in Tables";
	mso-style-link:"SOPn Text in Tables Char";
	margin-top:3.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	line-height:80%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#244061;}
span.SOPnTextinTablesChar
	{mso-style-name:"SOPn Text in Tables Char";
	mso-style-link:"SOPn Text in Tables";
	color:#244061;}
span.normaltextrun
	{mso-style-name:normaltextrun;}
span.eop
	{mso-style-name:eop;}
p.paragraph, li.paragraph, div.paragraph
	{mso-style-name:paragraph;
	margin-right:0cm;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
.MsoChpDefault
	{font-size:11.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:90.15pt 2.0cm 63.8pt 2.0cm;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=en-LU link=blue vlink=purple style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center'><b><u><span
lang=EN-GB>Information for the participant</span></u></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><u><span
lang=EN-GB>and informed consent form for patients</span></u></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-US>&nbsp;</span></b></p>

<div align=center>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=626 valign=top style='width:469.8pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
  <p class=MsoNormal style='text-align:justify'><b><u><span lang=EN-GB>Title of
  the study: </span></u></b><span lang=EN-GB>Co-design an electronic diary
  (eDiary) application for patients</span><b><span lang=EN-GB style='font-size:
  12.0pt'> </span></b><span lang=EN-GB style='font-size:12.0pt'>with<b> </b></span><span
  lang=EN-GB>Parkinson’s disease (PD) </span></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  <p class=MsoNormal><b><u><span lang=EN-GB>Acronym:</span></u></b><b><span
  lang=EN-GB> </span></b><span lang=EN-GB>MyPD</span></p>
  <p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>
  <p class=MsoNormal style='text-align:justify'><b><u><span lang=EN-GB>Sponsor
  of the study:</span></u></b><span lang=EN-GB> University of Luxembourg (UNILU)</span></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  <p class=MsoNormal style='text-align:justify'><b><u><span lang=EN-GB>Chief
  Scientific and Medical Investigator of the study:</span></u></b></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Prof. Dr. med.
  Jochen KLUCKEN</span></p>
  <p class=MsoNormal style='line-height:107%'><span lang=EN-GB>Luxembourg
  Centre for Systems Biomedicine University of Luxembourg Campus Belval,
  Biotech II-Annex 6, avenue du Swing L-4367 Belvaux, Luxembourg </span><span
  lang=EN-GB> </span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>Tel: </span><span
  lang=EN-US>+352 46 66 44 6399</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>Email:
  jochen.klucken@uni.lu</span></p>
  <p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>
  <p class=MsoNormal><b><u><span lang=EN-GB>Study assistant:</span></u></b><b><span
  lang=EN-GB> </span></b></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Name: Marijus
  Giraitis, clinician-scientist</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Contact
  details: </span><span class=normaltextrun><span lang=EN>marijus.giraitis@ext.uni.lu</span></span><span
  lang=EN> </span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Telephone: </span><b><span
  lang=DE-CH style='font-size:10.5pt;color:#393E46'>+</span></b><span
  lang=DE-CH style='font-size:10.5pt;color:#393E46'>352&nbsp;621 519 122</span></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>

<h1><span lang=EN-GB>1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>INTRODUCTION</span></h1>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>You are invited
to take part in a co-design study entitled “MyPD”. The purpose of this document
is to provide you with information on the study to help you decide if you would
like to take part. Your participation is entirely voluntary. If you decide to
take part, you may withdraw at any time without giving any reason.</span><span
lang=EN-GB> Your decision to withdraw from the study will not affect your
medical care.</span><span lang=EN-GB>  In addition, if your doctor deem your
state of health unsuitable to take part in the study at any point, he/she will
ask you to withdraw from the study. This study has received a favourable
opinion from</span><span lang=EN-GB> the National Research Ethics Committee on 01/03/2024</span><span
lang=EN-GB>. The ethics favourable opinion should not be taken as an incentive
to participate in this study.</span></p>

<h1><span lang=EN-GB>2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>WHAT IS THE PURPOSE OF THE
STUDY?</span></h1>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>The purpose of
this study is to co-design an electronic patient diary application (MyPD) as a digital
support to Parkinson’s disease (PD) patients in self-management and with health
knowledge. In this study we will collect information on the current status of
self-management and health knowledge in PD.</span><span lang=EN-GB> </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Co-design is an
approach that actively involves users of technology in the development of this
one – from the idea to the implementation of the technology in daily life.
Involvement of the users in the co-design of the technology ensures addressing
user needs and the acceptance and application of the technology by its users.  
</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Parkinson’s
disease (PD) is a complex disease with a variety of care needs. Management of
PD requires active involvement of various healthcare professionals (e.g.
neurologists, physiotherapists, nurses etc.), informal caregivers (e.g.
friends, family members) and people with PD themselves. In this study, we aim
to include the perspectives of the people involved in PD care to understand
self-management and health knowledge in PD in everyday life. This information
will allow guiding the development of the technology (MyPD) better fitting the
needs and providing optimal support. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>You have been
proposed to participate in this study because you are an adult person with a
diagnosed Parkinson’s disease. </span></p>

<h1><span lang=EN-GB>3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>HOW WILL THE STUDY BE
CONDUCTED?</span></h1>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-family:"Calibri",sans-serif'>The
study consists of 3 steps, a survey, interview and focus groups (workshops). You
may choose to participate in one or more steps according to your preference and
availability. </span><b><u><span lang=EN-GB style='font-size:11.0pt;font-family:
"Calibri",sans-serif'>Step 1</span></u></b><b><span lang=EN-GB
style='font-size:11.0pt;font-family:"Calibri",sans-serif'> – Survey</span></b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'> - 200-300
</span><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>PD
patients</span><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>
and 200-300 informal caregivers</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>Step
2</span></u></b><b><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>
– Interviews</span></b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Calibri",sans-serif'> - </span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Calibri",sans-serif'>10-12 PD patients and 5-7 informal caregivers</span></p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><u><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>Step
3</span></u></b><b><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>
– Focus groups</span></b><span lang=EN-GB style='font-size:11.0pt;font-family:
"Calibri",sans-serif'> -</span><span lang=EN-GB style='font-size:11.0pt;
font-family:"Calibri",sans-serif'>up to 10-12 participants per mixed focus
group (PD patients, informal caregivers and HCPs)</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN>Before consenting,
you will be informed about the study and its course. We will provide you with
the participant information sheet and give you sufficient time to ask questions
about the study.  If you decide to participate in the study, you will be asked
to sign 2 copies of the Informed Consent Form (ICF), one copy will be kept by
the study team and the other will be given to you for your records. </span><span
lang=EN-GB>If you choose to sign digital ICF, a tokenized and an online link
will be sent to your email so that you can access the electronic Ethical
Information Notice, Informed Consent Form, and Data Protection Notice, in the
language of your preference (English, French or German). After signing the
electronic ICF, you will be able to download a copy of this document and an
electronic copy will be sent to the study team who will contact you back to
on-board you on to the study. Signed electronic ICF will be kept in secure
server hosted by UNILU. </span><span lang=EN>After signing the ICF, you can choose
the step(s) of the study in which you are interested to participate. More
details are given in the following sections. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:14.0pt'>STEP 1 – Survey</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>If you  consent to
participate in STEP 1, a member of study team will explain you the procedure of
filling in the survey. You may select to complete the survey either in <b>digital</b>
or <b>paper</b> format. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>If you choose to fill in a <b>digital</b>
survey, please note the following;</span></p>

<p class=MsoListParagraphCxSpFirst style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Calibri",sans-serif;color:black'>1)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>You do not
need to download any application to fill out the survey. No account, login or
password needs to be created and you are expected to complete the survey once.</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Calibri",sans-serif;color:black'>2)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>You will
indicate if you are a PD patient or informal caregiver so that you are provided
with the respective token. You will be assigned a unique study ID allowing the separation
of your personal data from the survey data. The study team will provide you a
unique token and the link to the online survey. The token is needed to access
the survey. The token allows the linking of the survey filled by you to your
unique study ID.</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Calibri",sans-serif;color:black'>3)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>You can
open the link in your web browser and enter your token. Information about the
survey will appear. Once you have read this, you can start filling the survey. </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Calibri",sans-serif;color:black'>4)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>Upon
completion of the survey, you will be asked to indicate if you are interested to
participate in other study steps (interviews or focus groups). If you wish to
participate one/ or the other/or both steps, the study team will contact you</span><span
lang=EN-GB> </span><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>accordingly</span><span
lang=EN-GB>.</span></p>

<p class=MsoListParagraphCxSpLast style='text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>If you choose to
fill in a paper survey – a member of study team will provide you with a paper
version with a unique study ID number, for you to fill in. Questions on digital
and paper surveys are identical.</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>No personal
information (name, address or telephone number) will appear on the digital or
the paper survey. The survey is thus, only collected with a unique study ID. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>The purpose of
the survey is to collect information about self-management, health knowledge in
PD.</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>You will be
asked questions about your socio-demographic information (such as age,
education, living arrangement), your clinical status (e.g. symptoms, daily
activities) and your perspective on health knowledge and self-managing PD (e.g.
motivation, experience, daily practices). Filling the survey takes
approximately 40 min.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB> </span><b><span lang=EN-GB
style='font-size:14.0pt'>STEP 2 – Interviews</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>If you consent to
participate in STEP 2, a member of study team will explain the procedure for participating
in individual interviews which will be conducted face-to-face. The purpose of
individual interviews is to further explore self-management and health knowledge
in daily </span><span lang=EN-GB>PD patients’</span><span lang=EN-GB> life  and
collect more precise information on how technology (such as eDiary) can support
it.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Duration of
interview is approximately 60 minutes. Depending on your preferred language, interview
can be conducted in either, French, German or English. Interviews will be <b>audio</b>
<b>recorded</b> so that no information provided by you could be missed. After
the interview, the audio recording will be transcribed </span><span lang=EN-US>and
the recordings will be deleted one month after transcription</span><span
lang=EN-US>. </span><span lang=EN-US> </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:14.0pt'>STEP 3 – Focus
groups (workshops)</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>If you  consent  to
participate in STEP 3, a member of study team will explain you the procedure
and invite you to join one or more focus groups. Focus groups are small group
workshops aiming to collect information on participants’ interest in technology,
about their thoughts and ideas on technology. It will be organized face-to-face
with an approximate duration of up to 2 h. </span><span lang=EN-GB>A maximum of
12 focus groups will be organized. You will have the choice to participate in
one or more focus groups (no obligation to participate in all focus groups). </span><span
lang=EN-GB>Focus groups will be moderated in French, German or English. The language
of each focus group will be announced in advance, so you can choose the focus
group of your preferred language.</span><span lang=EN-GB> </span></p>

<p class=MsoNormal><span lang=EN-GB>The purpose of focus groups is to jointly
define and design the MyPD application developed to support </span><span
lang=EN-GB>PD patients</span><span lang=EN-GB> in self-management and health knowledge.
</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>During the focus
groups, we will focus on the following 4 aspects of the concept and
configuration of the MyPD:</span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>Content</span></b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>: the kind
of information (e.g. medical, socio-demographic) should be collected by the MyPD</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>User
interfaces</span></b><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>:
display and navigation (e.g. visual layout, structure)</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>User
journeys:</span></b><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>
everyday life use and needs (e.g. step-by-step plan, on-boarding, frequency,
needs for support)</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-GB
style='font-family:"Calibri",sans-serif'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>Visualization</span></b><span
lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'>:  the way
the information is provided through the display (e.g. reports generation,
additional app features)</span></p>

<p class=MsoNormal style='text-align:justify;line-height:107%'><span
lang=EN-GB>During the focus groups, study team may also request you to fill in some
questionnaires that will help us to improve the application design and collect
your feedback on the focus groups itself.  Focus groups will be audio<b>
recorded </b>to capture the discussion with accuracy and completeness. After
the focus group, audio recording will be transcribed onto paper and recordings
will be permanently deleted one month after transcription.</span></p>

<h1><span lang=EN-GB>4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>USE OF MY DATA</span></h1>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>You are invited
to provide your data for the purposes of medical research. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>In this study,
your data will be collected and analysed for the primary purpose, which is the co-design
of an electronic diary (MyPD) application with your feedback on the concept and
configuration as explained in previous sections. </span></p>

<h1><span lang=EN-GB>5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>WHAT ARE THE POSSIBLE RISKS?</span></h1>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>Although, all data will be
collected on the secure database and servers of UNILU, there is a risk
associated with data breaches or data loss (for example by hacking). This data
breach may include participants' personal data. This risk is small but exists.
The UNILU has implemented extensive data protection measures to minimize this
risk. These measures are explained in the &quot;Confidentiality and protection
of personal data&quot; section.</span></p>

<h1><span lang=EN-GB>6<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>WHAT ARE THE BENEFITS OF
TAKING PART IN THE STUDY?</span></h1>

<p class=MsoNormal style='margin-right:5.4pt'><i><span lang=EN-US>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-right:5.4pt;text-align:justify'><span
lang=EN-GB>You will not benefit directly by taking part in this study. Your
participation is voluntary. You will receive no form of compensation for your
involvement or from any subsequent developments resulting from the study. </span></p>

<p class=MsoNormal style='margin-right:5.4pt;text-align:justify'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.4pt;text-align:justify'><span
lang=EN-US>However, your participation is highly important to us, as it will
help increase current scientific knowledge </span><span lang=EN-GB>about
self-management and health knowledge in Parkinson’s disease. You will also have
a chance to learn about the development of health technologies and how such
solutions could support Parkinson’s disease patients in everyday life and
people involved in PD care.</span></p>

<h1><span lang=EN-GB>7<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>CONFIDENTIALITY AND
PROTECTION OF PERSONAL DATA</span></h1>

<p class=MsoNormal style='text-align:justify'><b><u><span lang=EN-US><span
 style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Your personal data
will be treated as strictly confidential. Your data will be pseudonymised,
meaning that your name will be replaced by a confidential unique study ID (such
as MYPDXXX). This study ID will not directly identify you and will only be used
to process your data for scientific purposes. Your identity will never be
disclosed in any document produced for the public or for other research
institutions. Apart from the study’s investigating doctor and the authorised
members of his team working under his responsibility (clinical team), only
authorized members of UNILU, who provide IT support services for data storing
platforms, could have access to your personal data if needed.   </span></p>

<p class=MsoNormal style='margin-bottom:8.0pt;text-align:justify;line-height:
107%'><span lang=EN-GB>If you consent to take part in the study, the data that
could identify you will be stored in accordance with the applicable laws and
guidelines. </span><span lang=EN-GB>The correspondence table between the
participants’ personal data and the study ID (pseudonyms) will be deleted 2
years after the end of the data collection in the study. </span><span
lang=EN-IE>UNILU will retain your data collected via the online survey,
individual interviews and focus groups in a pseudonymized form for 2 years,
followed by additional 8 years in</span><span lang=EN-IE> an anonymized form for
a total retention period of</span><span lang=EN-IE> 10 years following the end
of the study. Data will be stored within the UNILU secured databases. Audio
recordings from the interviews and focus groups will be deleted from the local
file within 1 month after the transcription performance. </span><span
lang=EN-IE>Emails of people contacting us directly will be deleted 6 months
after the first contact in case the person does not participate in the study. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-IE>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;text-autospace:none'><span
lang=EN-IE> </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>You will find
detailed information in the document about the data protection provided to you
by the study team before consenting to this study. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>

<h1><span lang=EN-GB>8<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>COSTS ASSOCIATED WITH YOUR
PARTICIPATION</span></h1>

<p class=MsoNormal style='text-align:justify'><span lang=FR>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Your
participation in the study will not incur any costs for you or your insurance. </span></p>

<h1><span lang=EN-GB>9<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>INSURANCE</span></h1>

<p class=MsoNormal style='text-align:justify'><u><span lang=FR><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>As a participant
in this study, you will have an insurance, which covers any damage caused to
your life or health by participating in the interview and/or focus group(s). If
needed and if you have questions, a copy of the insurance policy can be
provided to you. In the event of a claim, you can contact </span><span
lang=EN-GB>the principle investigator of the study who will evaluate your
request and contact</span><span lang=EN-GB> the insurer if needed. Luxembourg
law applies to the insurance contract, the insurance claims are enforceable in
Luxembourg. </span></p>

<p class=MsoNormal style='text-align:justify'><span class=normaltextrun><span
lang=EN-US>Insurance is acquired by University of Luxembourg </span></span><span
class=normaltextrun><span lang=EN-GB>for the study </span></span><span
class=normaltextrun><span lang=EN-US>and will cover all study-related activities
(interviews and focus group) as described in this document, as well as the risk
of data breaches for personal information. The insurance will only cover
activities carried out at the study site, and will not cover any activities or
accidents that might occur while arriving at the study center or leaving it.</span></span><span
class=eop><span lang=EN-US>&nbsp;</span></span></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<h1><span lang=EN-GB>10<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='color:black'>YOUR DECISION TO TAKE PART</span></h1>

<p class=MsoNormal style='text-align:justify'><span lang=FR>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>Your participation in the
study is voluntary. If you choose to take part, you may withdraw at any time
without giving a reason. Your decision to accept or decline to take part in
this study will in no way influence the quality of the care you are given. </span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>Before you take part in
the study, you will need to provide your written consent by completing the form
below.  You will receive your own copy of the document. Should you have any
questions about this study, you can contact the scientific PI Prof. Dr. med.
Jochen KLUCKEN or a member of the study’s clinical team at any time (see
contact details at the beginning of the document).</span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>If you would like further
information on </span><span lang=EN-GB>the study </span><span lang=EN-GB>please
contact:</span></p>

<p class=paragraph style='margin:0cm;text-align:justify;vertical-align:baseline'><span
class=normaltextrun><b><span lang=EN style='font-size:11.0pt;font-family:"Calibri",sans-serif'>For
medical-related questions:</span></b></span><span class=normaltextrun><span
lang=EN style='font-size:11.0pt;font-family:"Calibri",sans-serif'> </span></span><b><span
lang=DE-CH style='font-size:10.5pt;font-family:"Calibri",sans-serif;color:#393E46'>+</span></b><span
lang=DE-CH style='font-size:10.5pt;font-family:"Calibri",sans-serif;color:#393E46'>352&nbsp;621
519 122</span><span class=normaltextrun><span lang=EN style='font-size:11.0pt;
font-family:"Calibri",sans-serif'> or marijus.giraitis@ext.uni.lu</span></span></p>

<p class=paragraph style='margin:0cm;text-align:justify;vertical-align:baseline'><span
class=normaltextrun><b><span lang=EN style='font-size:11.0pt;font-family:"Calibri",sans-serif'>For
logistical questions:</span></b></span><span class=normaltextrun><span lang=EN
style='font-size:11.0pt;font-family:"Calibri",sans-serif'> </span></span><b><span
lang=DE-CH style='font-size:10.5pt;font-family:"Calibri",sans-serif;color:#393E46'>+</span></b><span
lang=DE-CH style='font-size:10.5pt;font-family:"Calibri",sans-serif;color:#393E46'>352&nbsp;621
519 122</span><span class=normaltextrun><span lang=EN style='font-size:11.0pt;
font-family:"Calibri",sans-serif'> or marijus.giraitis@ext.uni.lu</span></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span class=normaltextrun><b><span lang=EN>For
data protection related questions</span></b></span><span class=normaltextrun><span
lang=EN>: </span></span><span lang=EN-GB><a href="mailto:dpo@uni.lu"><span
class=normaltextrun><span lang=EN style='color:windowtext'>dpo@uni</span></span><span
lang=EN style='color:windowtext'>.lu</span></a></span><span
class=normaltextrun><u><span lang=EN>.</span></u></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Calibri",sans-serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>Informed
consent form&nbsp;</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>I declare that I have read and understood the
information provided above. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>I have had enough time to consider my
involvement in the study and to discuss it with a person of my choice, such as
my general practitioner or a member of my family. I have had the opportunity to
ask all of the questions that have occurred to me in relation to the study and
I have received satisfactory responses to each of them.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>I am aware of what is expected of me as a
participant in this study.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>I am aware that my participation in this study
is entirely voluntary and that I am free to withdraw at any time without giving
a reason for my decision and without being held liable for any material or
non-material damages. I will only need to inform the scientific PI or the
clinical team, of my decision.</span></p>

<p class=MsoNormal style='margin-left:18.0pt;text-align:justify;text-indent:
-18.0pt;line-height:115%'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>I accept that the results from this study may be disclosed and
reported in scientific publications. The way in which these results are
presented will in no way enable me to be identified, either directly or
indirectly.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>As described in the information document on the
processing of my personal data as part of this study I understand that any
personal information gathered in relation to this study will be treated as
strictly confidential, in accordance with the General Data Protection
Regulation (EU) 2016/679 of 27&nbsp;April 2016 (known as the GDPR) and all
subsequent texts replacing or supplementing this Regulation (in particular,
Luxembourg’s law of 1&nbsp;August 2018 on the organisation of its National
Commission for Data Protection and the implementation of the GDPR). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;
margin-left:17.85pt;text-align:justify;text-indent:-17.85pt'><span lang=EN-GB
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>I have received a copy of the present document,
together with the information document explaining how my personal data will be
processed as part of this study.</span></p>

<p class=MsoNormal style='margin-bottom:6.0pt;text-align:justify'><i><span
lang=EN-GB>In the table below, if you answer NO to any of the statements
followed by an asterisk (*), you will not be able to take part in the study, as
these are essential to its objectives.</span></i></p>

<p class=MsoNormal style='margin-bottom:6.0pt;text-align:justify'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width="74%" style='width:74.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width="12%" style='width:12.8%;border:solid windowtext 1.0pt;border-left:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>YES</span></b></p>
  </td>
  <td width="12%" style='width:12.34%;border:solid windowtext 1.0pt;border-left:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-GB>NO</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="74%" style='width:74.86%;border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=SOPnTextinTables style='text-align:justify'><span lang=EN-GB
  style='color:windowtext'>I willingly agree to take part in this study under
  the terms set out on the attached information sheet (*)  </span></p>
  </td>
  <td width="12%" style='width:12.8%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  <p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width="12%" style='width:12.34%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="74%" style='width:74.86%;border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=SOPnTextinTables style='text-align:justify'><span lang=EN-GB
  style='color:windowtext'>I consent to my interviews and the focus groups in
  which I participate being recorded in audio (*)</span></p>
  </td>
  <td width="12%" style='width:12.8%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  </td>
  <td width="12%" style='width:12.34%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="74%" style='width:74.86%;border:solid windowtext 1.0pt;border-top:
  none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=SOPnTextinTables style='text-align:justify'><span lang=EN-GB
  style='color:windowtext'>I agree to being contacted again by the person
  leading the study with a view to taking part in another study.</span></p>
  </td>
  <td width="12%" style='width:12.8%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  </td>
  <td width="12%" style='width:12.34%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-family:"MS Gothic"'>☐</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=FR-BE>&nbsp;</span></p>

<div align=center>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=654
 style='border-collapse:collapse;border:none'>
 <tr style='height:109.45pt'>
  <td width=654 valign=top style='width:490.45pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:109.45pt'>
  <p class=MsoNormal style='text-align:justify'><i><u><span lang=EN-GB>First
  name and surname of participant</span></u></i><i><span lang=EN-GB>:</span></i><span
  lang=EN-GB>................................................................................................. </span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify'><span lang=EN-GB>Date signed
  (day/month/year): ……………………… </span><span lang=EN-GB> </span><span lang=EN-GB> Signature
  of participant: </span><span lang=EN-GB>............................................... </span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>__ __ __ __ __
__ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __
__ __ __ __ __ _</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PART TO BE COMPLETED BY THE SCIENTIFIC PI OR
DELEGATE  </span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>I confirm that I have informed the
participant of the aims, the nature and the duration of the study, together
with the risks and procedures involved, and that he/she has agreed to take
part. </span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>First name and surname of PI assigned
clinical team member: </span><span lang=EN-GB>................................................................. </span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Date signed (day/month/year): </span><span
lang=EN-GB>........................... </span><span lang=EN-GB> Signature of clinical
team member: </span><span lang=EN-GB>............................ </span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-US>In duplicate,
one to be given to the participant and one to be retained by the principal
investigator of the study.</span><span lang=EN-US> </span></p>

<p class=MsoNormal style='margin-right:5.65pt'><span lang=EN-GB>__ __ __ __ __
__ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __
__ __ __ __ __ _</span></p>

<p class=MsoNormal style='margin-right:5.65pt'><a name="_Toc468094115"></a><a
name="_Toc468094116"></a><a name="_Toc468094117"></a><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
